291 related articles for article (PubMed ID: 25365149)
1. Hyper-IgE syndromes: reviewing PGM3 deficiency.
Yang L; Fliegauf M; Grimbacher B
Curr Opin Pediatr; 2014 Dec; 26(6):697-703. PubMed ID: 25365149
[TBL] [Abstract][Full Text] [Related]
2. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.
Sassi A; Lazaroski S; Wu G; Haslam SM; Fliegauf M; Mellouli F; Patiroglu T; Unal E; Ozdemir MA; Jouhadi Z; Khadir K; Ben-Khemis L; Ben-Ali M; Ben-Mustapha I; Borchani L; Pfeifer D; Jakob T; Khemiri M; Asplund AC; Gustafsson MO; Lundin KE; Falk-Sörqvist E; Moens LN; Gungor HE; Engelhardt KR; Dziadzio M; Stauss H; Fleckenstein B; Meier R; Prayitno K; Maul-Pavicic A; Schaffer S; Rakhmanov M; Henneke P; Kraus H; Eibel H; Kölsch U; Nadifi S; Nilsson M; Bejaoui M; Schäffer AA; Smith CI; Dell A; Barbouche MR; Grimbacher B
J Allergy Clin Immunol; 2014 May; 133(5):1410-9, 1419.e1-13. PubMed ID: 24698316
[TBL] [Abstract][Full Text] [Related]
3. Hyper-IgE Syndromes and the Lung.
Freeman AF; Olivier KN
Clin Chest Med; 2016 Sep; 37(3):557-67. PubMed ID: 27514600
[TBL] [Abstract][Full Text] [Related]
4. Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation.
Wu G; Hitchen PG; Panico M; North SJ; Barbouche MR; Binet D; Morris HR; Dell A; Haslam SM
Glycoconj J; 2016 Jun; 33(3):447-56. PubMed ID: 26687240
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene.
Lundin KE; Hamasy A; Backe PH; Moens LN; Falk-Sörqvist E; Elgstøen KB; Mørkrid L; Bjørås M; Granert C; Norlin AC; Nilsson M; Christensson B; Stenmark S; Smith CI
Clin Immunol; 2015 Dec; 161(2):366-72. PubMed ID: 26482871
[TBL] [Abstract][Full Text] [Related]
6. A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients.
Ben-Khemis L; Mekki N; Ben-Mustapha I; Rouault K; Mellouli F; Khemiri M; Bejaoui M; Essaddam L; Ben-Becher S; Boughamoura L; Hassayoun S; Ben-Ali M; Barbouche MR
Mol Immunol; 2017 Oct; 90():57-63. PubMed ID: 28704707
[TBL] [Abstract][Full Text] [Related]
7. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.
Zhang Y; Yu X; Ichikawa M; Lyons JJ; Datta S; Lamborn IT; Jing H; Kim ES; Biancalana M; Wolfe LA; DiMaggio T; Matthews HF; Kranick SM; Stone KD; Holland SM; Reich DS; Hughes JD; Mehmet H; McElwee J; Freeman AF; Freeze HH; Su HC; Milner JD
J Allergy Clin Immunol; 2014 May; 133(5):1400-9, 1409.e1-5. PubMed ID: 24589341
[TBL] [Abstract][Full Text] [Related]
8. An Update on Syndromes with a Hyper-IgE Phenotype.
Bergerson JRE; Freeman AF
Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
[TBL] [Abstract][Full Text] [Related]
9. Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report.
Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikström AC; Fasth A; Ekwall O; Smith CIE
BMC Pediatr; 2018 Aug; 18(1):285. PubMed ID: 30157810
[TBL] [Abstract][Full Text] [Related]
10. Primary Immunodeficiencies with Elevated IgE.
Mogensen TH
Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
[TBL] [Abstract][Full Text] [Related]
11. Hyper IgE syndromes: clinical and molecular characteristics.
Al-Shaikhly T; Ochs HD
Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
[TBL] [Abstract][Full Text] [Related]
12. Human hyper-IgE syndrome: singular or plural?
Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
[TBL] [Abstract][Full Text] [Related]
13. Profound differences in IgE and IgG recognition of micro-arrayed allergens in hyper-IgE syndromes.
Garib V; Ben-Ali M; Kundi M; Curin M; Yaakoubi R; Ben-Mustapha I; Mekki N; Froeschl R; Perkmann T; Valenta R; Barbouche MR
Allergy; 2022 Jun; 77(6):1761-1771. PubMed ID: 34653276
[TBL] [Abstract][Full Text] [Related]
14. Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients.
Jacob M; Masood A; Abdel Rahman AM
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768728
[TBL] [Abstract][Full Text] [Related]
15. Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features.
García-García A; Buendia Arellano M; Deyà-Martínez À; Lozano Blasco J; Serrano M; Van Den Rym A; García-Solis B; Esteve-Solé A; Yiyi L; Vlagea A; Solanich X; Fisher MR; Lyons JJ; de Diego RP; Alsina L
Pediatr Allergy Immunol; 2021 Apr; 32(3):566-575. PubMed ID: 33098103
[TBL] [Abstract][Full Text] [Related]
16. Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations.
Fusaro M; Vincent A; Castelle M; Rosain J; Fournier B; Veiga-da-Cunha M; Kentache T; Serre J; Fallet-Bianco C; Delezoide AL; Renesme L; Picard FM; Lasseaux E; Aladjidi N; Seta N; Cormier-Daire V; Schaftingen EV; Neven B; Moshous D; Blesson S; Picard C
J Clin Immunol; 2021 Jul; 41(5):958-966. PubMed ID: 33534079
[TBL] [Abstract][Full Text] [Related]
17. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
[TBL] [Abstract][Full Text] [Related]
18. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
[TBL] [Abstract][Full Text] [Related]
19. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
Alcántara-Montiel JC; Vega-Torres BI
Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
[TBL] [Abstract][Full Text] [Related]
20. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
